MDC.AX
Medlab Clinical Ltd
Price:  
6.60 
AUD
Volume:  
49.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDC.AX Stock Forecast & Price Target

MDC.AX Stock Price Forecast

The average stock forecast for Medlab Clinical Ltd (MDC.AX) in the next 12 months is 19.22 AUD. This price target corresponds to an upside of 191.16%. The range of stock forecasts for MDC.AX is 19.03 - 19.78 AUD. Based on the ratings of 5 analysts, the consensus recommendation for MDC.AX is BUY.
Target Low Average Median High
Price (AUD) 19.03 19.22 19.22 19.78
Upside 188.31% 191.16% 191.16% 199.73%

Recommendation Trends

The latest consensus rating for MDC.AX is "BUY". This is the average recommendation of 5 analysts: 0 strong sell, 0 sell, 1 hold, 3 buy, 1 strong buy. In the previous period, 5 analysts also majorly recommmended "BUY" for MDC.AX.

MDC.AX Financial Stock Forecast

Revenue This Year
6.87M
46,908.90%
from 0.01M
Revenue Next Year
from 6.87M
EPS This Year
-1.12
20.14%
from -0.93
EPS Next Year
from -1.12